Grufity logoGrufity logo
StocksFundsSearch Filings

Davita Inc Stock Research

DVA

98.74USD+4.03(+4.26%)Market Closed

Market Summary

USD98.74+4.03
Market Closed
4.26%

DVA Alerts

DVA Stock Price

DVA RSI Chart

DVA Valuation

Market Cap

9.0B

Price/Earnings (Trailing)

17.42

Price/Sales (Trailing)

0.77

EV/EBITDA

10.24

Price/Free Cashflow

8.31

DVA Price/Sales (Trailing)

DVA Profitability

EBT Margin

8.32%

Return on Equity

78.67%

Return on Assets

3.31%

Free Cashflow Yield

12.03%

DVA Fundamentals

DVA Revenue

Revenue (TTM)

11.7B

Revenue Y/Y

1.96%

Revenue Q/Q

-1.51%

DVA Earnings

Earnings (TTM)

513.8M

Earnings Y/Y

-28.73%

Earnings Q/Q

69.67%

Price Action

52 Week Range

65.28103.00
(Low)(High)

Last 7 days

4.7%

Last 30 days

12%

Last 90 days

20.4%

Trailing 12 Months

2.0%

DVA Financial Health

Current Ratio

1.2

Debt/Equity

12.2

Debt/Cashflow

0.18

DVA Investor Care

Buy Backs (1Y)

4.82%

Diluted EPS (TTM)

5.46

Peers (Alternatives to Davita)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
75.7B
60.9B
-1.42% 30.28%
13.2
1.24
1.94% -15.77%
20.7B
14.8B
-3.99% -12.29%
16.22
1.39
-6.96% -52.35%
15.2B
9.6B
-0.74% -1.22%
19.15
1.58
-10.08% -57.84%
MID-CAP
9.9B
13.6B
-4.97% 10.44%
14.64
0.74
5.04% -26.87%
9.0B
11.7B
12.00% 1.95%
17.42
0.77
0.42% -43.11%
8.1B
2.2B
-1.40% 11.87%
33.9
3.75
1.03% -10.38%
6.3B
2.7B
2.27% -2.33%
22.71
2.34
13.37% 15.12%
6.1B
4.4B
-0.25% 20.85%
22.47
1.4
8.15% -30.89%
4.0B
4.8B
18.04% 0.73%
10.48
0.83
3.57% -4.88%
3.7B
786.9M
14.43% 23.72%
85.46
4.68
57.19% -22.51%
SMALL-CAP
732.6M
-
0.48% -14.75%
19.64
0.62
- -
394.4M
146.1M
-8.41% 71.93%
63.38
2.84
20.87% -35.06%
12.4M
14.5M
4.32% -75.57%
-0.24
0.86
-82.75% -38.85%
10.6M
17.9M
- -
-0.75
0.59
26.72% -85.04%

Financials for Davita

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Revenue0.5%11,66511,61011,63711,62711,616
  S&GA Expenses2.7%1,3921,3551,2981,2261,209
Costs and Expenses0.8%10,35310,27110,1659,9919,923
EBITDA-8.0%1,6991,8472,0102,359-
EBITDA Margin-7.8%0.15*0.16*0.17*0.20*-
Earnings Before Taxes-5.0%9189661,1341,3211,404
EBT Margin-14.6%0.08*0.10*0.11*0.12*-
Net Income-8.3%514560680834903
Net Income Margin-17.4%0.05*0.06*0.07*0.08*-
Free Cahsflow-16.6%9611,1529951,479-
Balance Sheet
(In Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Assets-1.2%16,72816,92816,96217,10117,087
  Current Assets-3.7%3,0403,1553,2023,2643,129
    Cash Equivalents68.5%411244368263328
  Inventory-2.2%107109107110108
  Net PPE-1.2%3,2163,2563,2403,3053,439
  Goodwill0.2%7,0907,0777,0237,0207,073
Liabilities-2.7%14,30914,70314,88914,94014,678
  Current Liabilities-2.1%2,5652,6202,5372,3112,420
  Long Term Debt-3.2%8,4188,6938,8679,0658,687
Shareholder's Equity15.9%825712533605844
  Retained Earnings66.2%290174847741516
  Additional Paid-In Capital-2.7%590607609578595
Shares Outstanding0.3%91.0090.0090.0092.0095.00
Minority Interest18.9%194164169170175
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Cashflow From Operations9.0%1,7051,5651,7511,6072,099
  Share Based Compensation0.5%96.0095.00104101104
Cashflow From Investing0.3%-628-630-753-764-778
Cashflow From Financing5.9%-1,055-1,121-1,664-1,683-1,961
  Buy Backs-29.4%5668021,4581,5961,459

Risks for DVA

What is the probability of a big loss on DVA?

86.9%


Probability that Davita stock will be more than 20% underwater in next one year

36.9%


Probability that Davita stock will be more than 30% underwater in next one year.

17.3%


Probability that Davita stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does DVA drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Davita was unfortunately bought at previous high price.

Drawdowns

Returns for DVA

Cumulative Returns on DVA

4.7%


10-Year Cumulative Returns

3.6%


7-Year Cumulative Returns

8.0%


5-Year Cumulative Returns

6.9%


3-Year Cumulative Returns

What are the long-term rolling returns for DVA?

FIve years rolling returns for Davita.

Annualized Returns

Which funds bought or sold DVA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-06-01
MACQUARIE GROUP LTD
unchanged
-
201,592
2,546,500
-%
2023-05-31
Coastline Trust Co
unchanged
-
38,447
484,227
0.07%
2023-05-26
ProShare Advisors LLC
reduced
-54.43
-704,421
690,489
-%
2023-05-25
Brandywine Global Investment Management, LLC
added
141
16,570,600
26,774,600
0.11%
2023-05-23
Front Row Advisors LLC
added
25.00
2,000
6,000
-%
2023-05-23
Toroso Investments, LLC
added
155
1,810,000
2,832,000
0.05%
2023-05-22
AMERIPRISE FINANCIAL INC
reduced
-94.93
-35,556,900
2,073,060
-%
2023-05-18
NEW YORK STATE COMMON RETIREMENT FUND
reduced
-5.09
145,000
4,856,000
0.01%
2023-05-18
JPMORGAN CHASE & CO
added
39.97
4,547,890
13,281,900
-%
2023-05-18
SkyView Investment Advisors, LLC
new
-
-
-
-%

1–10 of 40

Latest Funds Activity

Are funds buying DVA calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own DVA
No. of Funds

Davita News

MarketBeat
Zacks Research Research Analysts Lift Earnings Estimates for ....
MarketBeat,
18 hours ago
MarketWatch

Schedule 13G FIlings of Davita

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2023
vanguard group inc
6.84%
6,166,112
SC 13G/A
Feb 01, 2023
blackrock inc.
5.4%
4,822,086
SC 13G/A
Feb 14, 2022
berkshire hathaway inc
37.5%
36,095,570
SC 13D/A
Feb 09, 2022
vanguard group inc
7.34%
7,481,018
SC 13G/A
Feb 01, 2022
blackrock inc.
5.5%
5,654,952
SC 13G/A
Aug 04, 2021
berkshire hathaway inc
34.4%
36,095,570
SC 13D/A
Feb 16, 2021
berkshire hathaway inc
33.0%
36,095,570
SC 13D/A
Feb 10, 2021
vanguard group inc
7.69%
8,611,932
SC 13G/A
Jan 29, 2021
blackrock inc.
5.3%
5,939,662
SC 13G/A
Sep 21, 2020
berkshire hathaway inc
31.7%
36,095,570
SC 13D/A

DVA Fair Value

Show Fair-Value

Recent SEC filings of Davita

View All Filings
Date Filed Form Type Document
May 17, 2023
4
Insider Trading
May 17, 2023
4
Insider Trading
May 17, 2023
4
Insider Trading
May 17, 2023
4
Insider Trading
May 17, 2023
4
Insider Trading
May 17, 2023
4
Insider Trading
May 17, 2023
4
Insider Trading
May 17, 2023
4
Insider Trading
May 17, 2023
4
Insider Trading
May 17, 2023
4
Insider Trading

Latest Insider Trading transactions for DVA

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-05-15
Rodriguez Javier
sold (taxes)
-3,981,240
96.86
-41,103
chief executive officer
2023-05-15
DIAZ PAUL J
acquired
-
-
516
-
2023-05-15
NEHRA JOHN M
acquired
-
-
516
-
2023-05-15
DESOER BARBARA J
acquired
-
-
516
-
2023-05-15
BERG CHARLES
acquired
-
-
516
-
2023-05-15
YALE PHYLLIS R
acquired
-
-
516
-
2023-05-15
STAFFIERI MICHAEL DAVID
sold (taxes)
-1,912,600
96.86
-19,746
chief operating officer, dkc
2023-05-15
Hollar Jason M.
acquired
-
-
516
-
2023-05-15
Schechter Adam H
acquired
-
-
516
-
2023-05-15
Moore Gregory J.
acquired
-
-
516
-

1–10 of 50

Javier J. Rodriguez
65535
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

DVA Income Statement

2023-03-31
CONSOLIDATED STATEMENTS OF INCOME (unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]  
Dialysis patient service revenues$ 2,760,034$ 2,716,281
Other revenues112,665101,274
Total revenues2,872,6992,817,555
Operating expenses:  
Patient care costs2,058,1892,018,529
General and administrative331,614294,820
Depreciation and amortization178,071172,944
Equity investment income, net(6,820)(7,046)
Total operating expenses2,561,0542,479,247
Operating income311,645338,308
Debt expense(100,774)(73,791)
Other income (loss), net3,752(1,786)
Income before income taxes214,623262,731
Income tax expense43,95557,013
Net income170,668205,718
Less: Net income attributable to noncontrolling interests(55,121)(43,596)
Net income attributable to DaVita Inc.$ 115,547$ 162,122
Earnings per share attributable to DaVita Inc.:  
Basic net income$ 1.28$ 1.68
Diluted net income$ 1.25$ 1.61
Weighted average shares for earnings per share:  
Basic (in shares)90,49796,342
Diluted (in shares)92,483100,503

DVA Balance Sheet

2023-03-31
CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
ASSETS  
Cash and cash equivalents$ 317,132$ 244,086
Restricted cash and equivalents94,26594,903
Short-term investments49,96577,693
Accounts receivable, net2,057,8092,132,070
Inventories106,770109,122
Other receivables324,405413,976
Prepaid and other current assets89,39378,839
Income tax receivable04,603
Total current assets3,039,7393,155,292
Property and equipment, net3,216,3733,256,397
Operating lease right-of-use assets2,617,0182,666,242
Intangible assets, net186,758182,687
Equity method and other investments241,747231,108
Long-term investments44,52044,329
Other long-term assets291,321315,587
Goodwill7,090,3117,076,610
Total assets16,727,78716,928,252
LIABILITIES AND EQUITY  
Accounts payable447,969479,780
Other liabilities796,742802,469
Accrued compensation and benefits618,931692,654
Current portion of operating lease liabilities394,607395,401
Current portion of long-term debt242,193231,404
Income tax payable64,65118,039
Total current liabilities2,565,0932,619,747
Long-term operating lease liabilities2,455,1442,503,068
Long-term debt8,417,5328,692,617
Other long-term liabilities100,229105,233
Deferred income taxes771,087782,787
Total liabilities14,309,08514,703,452
Commitments and contingencies:  
Noncontrolling interests subject to put provisions1,398,8291,348,908
Equity:  
Preferred Stock, Value, Issued00
Common Stock, Value, Issued9190
Additional paid-in capital590,251606,935
Retained earnings290,034174,487
Accumulated other comprehensive loss(54,906)(69,186)
Total DaVita Inc. shareholders' equity825,470712,326
Noncontrolling interests not subject to put provisions194,403163,566
Total equity1,019,873875,892
Total liabilities and equity$ 16,727,787$ 16,928,252